Cargando…
Association of metformin use on metabolic acidosis in diabetic patients with chronic hepatitis B‐related cirrhosis and renal impairment
BACKGROUND AND AIMS: Metformin is an oral anti‐hyperglycemic recommended by the American Diabetes Association (ADA) as a preferred initial pharmacologic agent for type 2 diabetes. Metabolic acidosis is a rare yet severe side effect of it. We examined the association of metformin use and dosage on th...
Autores principales: | Yip, Terry Cheuk‐Fung, Chan, Raymond Ngai Chiu, Wong, Vincent Wai‐Sun, Tse, Yee‐Kit, Liang, Lilian Yan, Hui, Vicki Wing‐Ki, Zhang, Xinrong, Li, Guan‐Lin, Chan, Henry Lik‐Yuen, Wong, Grace Lai‐Hung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358231/ https://www.ncbi.nlm.nih.gov/pubmed/34401527 http://dx.doi.org/10.1002/hsr2.352 |
Ejemplares similares
-
Colonoscopy and Risk of Colorectal Cancer in Patients With Nonalcoholic Fatty Liver Disease: A Retrospective Territory‐Wide Cohort Study
por: Zhang, Xinrong, et al.
Publicado: (2021) -
Aspirin Reduces the Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Oral Nucleos(t)ide Analog
por: Hui, Vicki Wing-Ki, et al.
Publicado: (2021) -
U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases
por: Lin, Huapeng, et al.
Publicado: (2022) -
Baveno VII criteria for recompensation predict transplant-free survival in patients with hepatitis B-related decompensated cirrhosis
por: Hui, Vicki Wing-Ki, et al.
Publicado: (2023) -
Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B
por: Liang, Lilian Yan, et al.
Publicado: (2021)